This PrEP Action Kit includes clinical resources to help providers incorporate PrEP into their practices. Including helpful resources such as tips on taking a comprehensive sexual history, frequently asked questions about PrEP and information on PrEP prescribing and monitoring. This action kit is an essential resource for all providers treating LGBTQIA+ patients or patients at risk of HIV infection.
Learning Resources — Pre-Exposure Prophylaxis (PrEP)
Innovative Methods for Delivering Pre-Exposure Prophylaxis (PrEP) Care
Presented by Dr. Kevin Ard, participants will learn about innovative approaches to HIV prevention using a status-neutral framework with information on telehealth for pre-exposure prophylaxis (PrEP), PrEP On Demand, and more. The webinar also provides the most recent information about how to implement long-acting injectable PrEP at health centers.
HIV Prevention Learning Collaborative Summary
From December 2020 through April 2023, the National LGBTQIA+ Health Education Center developed and facilitated three HIV prevention learning collaborative cohorts involving 29 organizations and 79 participants. Participants represented a range of role groups within health centers and worked in diverse locations around the country. Overall, participants described a significant amount of knowledge gained from the sessions and satisfaction with the training. Two of the cohorts overlapped with the Covid-19 pandemic; the learning collaborative’s virtual format was conducive to pandemic limitations on in-person gatherings, and the program provided a strategy to continue building capacity for PrEP during and despite the pandemic. Key lessons from the learning collaborative program include the importance of training about logistical and programmatic aspects of PrEP, the feasibility and desirability of engaging multidisciplinary teams in PrEP training, balancing education about scientific advancements in PrEP with content on implementation and addressing HIV risk perception and adherence. Going forward, we aim to create new content on risk perception and adherence and institute systematic evaluations of the learning collaborative cohorts to facilitate ongoing innovation and improvement.
What’s Next in PrEP?: New Strategies for Prevention
Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis was approved in the United States. Since then, the landscape of PrEP has shifted, with approval of additional PrEP medications and growth of low-threshold PrEP delivery strategies, such as same-day PrEP. In this interactive webinar, participants will learn about new medications in the pipeline for PrEP and emerging PrEP delivery models.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
Financing PrEP in the Current Era
In this webinar, Dr. Kevin Ard discussed recent developments in the field of PrEP, such as licensure of long-acting injectable medication for HIV pre-exposure prophylaxis (PrEP), availability of a generic PrEP formulation, and concerns about the 340B program. These developments have led to questions about financing PrEP in 2023 and beyond. In this interactive session, experts on PrEP will discuss the current PrEP financing landscape and what may be in store for the future.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
Promoting Health Equity for Black Transgender MSM in HIV Prevention, Treatment, and Access
Join us for a fireside chat with Dr. Tonia Poteat, PhD, PA-C, MPH from the UNC Center for Health Equity Research and Deborah Dunn where they discuss the importance of promoting health equity for Black Trans MSM seeking HIV prevention, treatment or testing. Topics include, but are not limited to discussing the effects of racism, transphobia, and other risk factors that contribute to medical mistrust in the Black and Trans community, as well as, the unique sexual and reproductive health needs of Black Trans MSM.
PrEP and Transgender Communities: Evidence Informed Practices
In this talk from the 2022 Advancing Excellence in Transgender Health Care Conference, Dr. Tonia Poteat discusses evidence-informed practices for PrEP and Transgender communities. By the end of this talk, you will be able to describe current and pipeline options for PrEP, have reviewed existing data on PrEP among transgender people, and identify gender-affirming practices for PrEP implementation.
Innovative Models for HIV Prevention and Care
In this interactive webinar, participants will learn about novel approaches to HIV prevention and care, including status-neutral care paradigms, same-day pre-exposure prophylaxis (PrEP), and rapid antiretroviral start programs. The webinar will also provide up-to-date information about how to implement long-acting injectable PrEP at health centers.
Long-Acting Injectable PrEP for HIV: What Health Centers Need to Know
Long-acting injectable cabotegravir was approved for HIV pre-exposure prophylaxis in late 2021. In this interactive webinar, participants will learn about the effectiveness, advantages, and disadvantages of long-acting injectable cabotegravir as well as the clinical and programmatic steps to incorporate it into practice.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
New PrEP Guidelines
In this webinar, Dr. Kevin Ard will provide updated guidance related to PrEP, informed by new PrEP guidelines and the FDA approval of injectable PrEP.
- Filed under
- Pre-Exposure Prophylaxis (PrEP)
